Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT05389293 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial
NCT05389293 · ClinicalTrials.gov record · last posted 2026-08-10

A Study of Mosunetuzumab Alone or With Zanubrutinib in People With Follicular Lymphoma

StatusRecruiting
PhasePhase 2
Started2022-05-27
View on ClinicalTrials.gov ↗
from the ClinicalTrials.gov record
The purpose of this study is to find out if mosunetuzumab is an effective treatment in people with follicular lymphoma that was recently diagnosed and have not yet received any treatments for their disease.

Protocol amendment history 2 changes detected by DataLookout

2026-08-11
Primary completion pushed: 2026-12 → 2027-12
2026-08-11
Completion pushed: 2026-12 → 2027-12
Trial Details
NCT Number NCT05389293
Lead Sponsor Memorial Sloan Kettering Cancer Center
Conditions Follicular Lymphoma, Lymphoma
Enrollment 152 participants
Start Date 2022-05-27
Primary Completion 2027-12 (estimated)
Study Completion 2027-12 (estimated)
Updated on ClinicalTrials.gov 2026-08-10